Stocktoria

BillionToOne, Inc. BLLN

Nasdaq · stock · Services-Medical Laboratories · website · IPO 2025-11-06

BillionToOne, Inc. statistics & valuation

Market cap$5.4B
P / E729.2×
P / S17.8×
P / B11.3×
P / FCF345.9×
Net margin2.4%
Return on equity1.6%
FCF margin5.2%
Net cash$438.7M
Net debt / EBITDA-19.1×
Enterprise value USD$5.0B
Earnings yield EBIT/EV0.3%
Return on capital2.7%
Graham number -91.3%$8.44

Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports. The Graham number is Benjamin Graham's rough maximum fair value ($8.44); a green figure means the price is below it.

Profitability & efficiency

Net margin (%)
-27.20% 2.40% 20242025
Gross margin (%)
53.00% 68.30% 20242025
Operating margin (%)
-30.90% 5.30% 20242025
Return on equity (%)
1.60% 20242025
Shares outstanding
10.9M 21.2M 20242025
Net debt ($)
-$140.0M -$438.7M 20242025
Share buybacks ($)
20242025
Return on assets (%)
-13.80% 1.20% 20242025
Free cash flow margin (%)
-30.70% 5.20% 20242025
Debt / equity (×)
0.12× 20242025
EPS ($)
-$4.12 $0.14 20242025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

Key ratios (by fiscal year)

RatioFY2025FY2024
Gross margin68.3%53.0%
Operating margin5.3%-30.9%
Net margin2.4%-27.2%
FCF margin5.2%-30.7%
Return on assets1.2%-13.8%
Return on equity1.6%16.5%
Debt / equity0.12×-0.20×
Current ratio11.698.03

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.